Stock listing

OTC:ACUR Acura Pharmaceuticals, Inc. Stock

Follow Acura Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · OTC:ACUR

$0.0003 USD 0.0000 (0.0%)

Close on Nov 17, 2026

Past year +50.0% · daily closes, Nov 18, 2025 – Nov 17, 2026, adjusted for splits
Day range
$0.0003 – $0.0003 USDNov 17, 2026
Volume
200 sharesNov 17, 2026
Market cap
$19,801 USDAt the close on Nov 17, 2026 · price × 66.00M shares outstanding
52-week range
$0.0001 – $0.0009 USDLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
$0 USDMedian day 0 shares · 43 days with no trades · last 3 months, Aug 17, 2026 – Nov 17, 2026
Acura Pharmaceuticals, Inc. logo

Daily closes

Last 3 months, Aug 17, 2026 – Nov 17, 2026 · OTC:ACUR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00030.00000.0%$0.0003$0.0003$0.0003200
$0.00030.00000.0%$0.0003$0.0003$0.00036,184
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.0003+0.0001+50.0%$0.0003$0.0003$0.0003200
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00022,395
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000135,044
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00011,113
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001500
$0.00010.00000.0%$0.0001$0.0001$0.0001200
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000134,348
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001120
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001300
$0.00010.00000.0%$0.0001$0.0001$0.00011,050
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00012,221
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0004$0.0004$0.0001400
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001265
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001400
$0.00010.00000.0%$0.0001$0.0001$0.0001112
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000112,900
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010

Splits

2 splits since 2007 · OTC:ACUR · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-10Consolidation
Ticker
OTC:ACUR
Asset type
Stock
Exchange
OTC
Currency
USD

Acura Pharmaceuticals, Inc. on 6ix

Decks
11 decks · latest Sep 11, 2017

Valuation

price Nov 17, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
-0.56

Events

QuarterResultsShare move
Quarter to Sep 30, 2024Nov 18, 20240.0%
Quarter to Jun 30, 2024Aug 20, 2024+2.8%
Quarter to Mar 31, 2024May 21, 2024+66.7%
Quarter to Dec 31, 2023Feb 28, 2024+220.0%
Quarter to Sep 30, 2023Nov 13, 2023
Quarter to Jun 30, 2023Aug 7, 2023 · After close0.0%
Quarter to Mar 31, 2023Jun 30, 2023 · After close
Quarter to Dec 31, 2022Mar 3, 2023 · After close
Quarter to Sep 30, 2022Nov 14, 2022
Quarter to Jun 30, 2022Aug 15, 2022
All 16 quarters
QuarterResultsShare move
Quarter to Mar 31, 2022May 2, 2022
Q4 2021Mar 31, 2022
Q3 2021Nov 15, 2021
Q2 2021Aug 16, 2021
Q1 2021May 17, 2021
Q4 2020Mar 31, 2021

Open Events

Decks

DeckKindSlidesDate
Rodman & Renshaw Conference 2017Conference24 slidesSep 11, 2017
Technical Presentation (June 2017)Technical11 slidesJun 28, 2017
Technical Presentation (July 2016)Technical14 slidesJul 13, 2016
Technical Presentation (June 2016)Technical12 slidesJun 8, 2016
Technical Presentation (April 2016)Technical13 slidesApr 14, 2016
Investor Presentation (March 2016)Investor deck19 slidesMar 11, 2016
Investor Presentation (September 2015)Investor deck23 slidesSep 28, 2015
Roth Capital Conference March 2014Conference27 slidesMar 10, 2014
Cowen Health Care Conference 2013Conference26 slidesMar 4, 2013
Stifel Nicolaus Conference 2012Conference20 slidesSep 4, 2012
All 11 decks
DeckKindSlidesDate
Needham & Company Healthcare Conference 2012Conference24 slidesApr 2, 2012

Open Decks

Financials

Annual, in USD

Income statement

LineFY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012
Revenue1.56M3.57M2.66M410.0K2.97M4.46M8.59M751.0K123.0K
Cost of revenue0128.0K477.0K986.0K5.01M364.0K9.61M
Gross profit3.57M2.66M410.0K2.84M3.99M7.60M-4.26M-241.0K
Research and development1.52M1.78M1.50M1.76M3.72M4.03M2.61M4.58M4.92M3.73M
Selling, general and administrative1.25M2.55M1.88M2.57M4.34M6.52M8.99M7.94M8.93M6.01M
Operating income-1.21M-758.0K-725.0K-3.92M-5.22M-6.56M-4.00M-12.2M-14.1M-9.74M
Depreciation and amortization90.0K125.0K339.0K367.0K393.0K490.0K518.0K274.0K134.0K131.0K
EBITDA-1.12M-633.0K-386.0K-3.55M-4.83M-6.07M-3.48M-11.9M-14.0M-9.61M
Interest expense200.0K450.0K462.0K395.0K000000
Income before tax-879.0K-1.21M-3.77M-3.84M-5.82M-7.39M-4.99M-13.2M-13.9M-9.67M
Income tax-135.0K0000
Net income-879.0K-1.21M-3.77M-3.84M-5.68M-7.39M-4.99M-13.2M-13.9M-9.67M
Earnings per share, basic-0.01-0.06-0.18-0.18-0.27-0.62-0.42-0.29

Balance sheet

LineFY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012
Cash and equivalents65.0K413.0K862.0K91.0K2.22M5.18M2.48M774.0K12.3M7.48M
Short-term investments010.8M11.3M13.7M19.9M
Receivables158.0K627.0K34.0K67.0K71.0K23.0K295.0K142.0K500.0K43.0K
Inventory0309.0K276.0K304.0K251.0K219.0K
Current assets372.0K1.18M1.18M461.0K2.57M5.91M14.1M13.2M27.5M28.0M
Property, plant and equipment484.0K540.0K606.0K679.0K867.0K1.01M957.0K941.0K1.05M
Total assets860.0K1.74M2.56M2.15M4.60M8.21M17.0M16.0M28.6M29.1M
Accounts payable192.0K662.0K822.0K1.20M1.64M780.0K674.0K217.0K815.0K1.41M
Current liabilities515.0K7.52M1.07M1.44M4.63M3.49M3.24M2.99M1.11M1.42M
Long-term debt150.0K105.0K6.00M4.22M2.98M5.43M7.80M9.60M
Total liabilities682.0K7.63M7.30M5.77M4.63M7.03M9.06M11.0M10.7M1.42M
Shareholders' equity178.0K-5.89M-4.74M-3.62M-27.0K1.18M7.90M5.05M17.9M27.6M
Shares outstanding65.1M21.6M21.3M21.0M20.8M11.8M11.8M48.3M

Cash flow

LineFY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012
Cash from operations-742.0K-719.0K-618.0K-3.91M-4.51M-5.56M-3.69M-11.0M-13.7M-7.04M
Capital spending00000-75.0K-214.0K-135.0K-23.0K-147.0K
Free cash flow-742.0K-719.0K-618.0K-3.91M-4.51M-5.64M-3.90M-11.2M-13.7M-7.18M
Cash from investing309.0K10.8M108.0K-2.00K6.25M-20.1M
Cash from financing394.0K270.0K1.39M1.78M1.24M-2.54M5.29M-520.0K12.3M-1.04M
Share buybacks4.00M1.00K-610.0K9.00K10.0K10.0K
Change in cash-348.0K-449.0K771.0K-2.13M-2.96M2.70M1.71M-11.6M4.86M-28.2M

Open Financials

Cap table

Built by 6ix from Acura Pharmaceuticals, Inc.’s releases

Common shares
66,001,783
Fully diluted
66,001,783

Fully diluted

LineShares
Common shares66,001,783

Share count over time

CountShares
Nov 22, 202666,001,783

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Ancora Advisors LLC500<0.01%Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard J Markham
Other companies: Vaxart, Inc. (Director · Feb 13, 2018 – Jun 12, 2019 · Past); CoLucid Pharmaceuticals Inc (Director · May 5, 2015 – May 11, 2015 · Past); NephroGenex Inc (Director · Feb 10, 2014 – Apr 30, 2015 · Past)
Director · Jan 2, 2009 – Jan 2, 2013 · Past
Albert W BrzeczkoSee Remarks · Feb 9, 2009 – Nov 20, 2023 · Past
Bruce F WessonDirector · Jan 2, 2024 – Jan 2, 2024 · Past
George K RossDirector · Since at least Jan 2, 2009
Immanuel ThangarajDirector · Since at least Jan 2, 2026
James F EmighVP, Corporate Development · Jan 4, 2021 – Feb 24, 2021 · Past
J Bradley RivetVP Marketing · Oct 3, 2011 – Dec 8, 2016 · Past
Peter A ClemensSenior VP & CFO · Dec 8, 2016 – Nov 20, 2023 · Past
Robert B JonesPresident & CEO · Dec 8, 2016 – Nov 20, 2023 · Past
William G SkellyDirector · Since at least Nov 14, 2008

Open People

Log in to ask 6ix AI your own questions about Acura Pharmaceuticals, Inc.